Production (Stage)
Autolus Therapeutics plc
AUTL
$1.54
$0.010.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -238.13M | -220.66M | -270.23M | -233.98M | -221.26M |
| Total Depreciation and Amortization | 8.19M | 7.72M | 7.41M | 6.86M | 6.47M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.23M | 30.33M | 66.52M | 80.10M | 71.12M |
| Change in Net Operating Assets | -27.60M | -23.66M | 3.13M | -9.59M | -9.00K |
| Cash from Operations | -241.32M | -206.27M | -193.17M | -156.62M | -143.68M |
| Capital Expenditure | -29.79M | -22.08M | -12.44M | -4.35M | -7.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -423.78M | -372.48M | -- | -- | -- |
| Cash from Investing | -453.57M | -394.55M | -12.44M | -4.35M | -7.90M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 317.00K | 550.58M | 550.60M | 550.41M | 550.29M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 27.80M | 38.98M | 8.98M | 8.98M | 10.96M |
| Cash from Financing | 28.11M | 589.55M | 559.57M | 559.39M | 561.25M |
| Foreign Exchange rate Adjustments | 4.48M | -261.00K | 47.73M | 705.00K | 6.52M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -662.29M | -11.53M | 401.69M | 399.13M | 416.19M |